OPNT

Opiant Pharmaceuticals, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 4/18/2017
Contact Info
  • 401 Wilshire Blvd.
  • 12th Floor
  • Santa Monica, CA 90401

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jan 31, 2017 10-Q
CIK 0001385508
Fiscal Year End 7/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 1000 - Metal Mining
Incorporated In: NV, USA
Year of Inc. 2005
Employees 8 a/o Apr 17, 2017
Company Officers/Contacts
Roger Crystal CEO, President
Kevin Pollack CFO, Treasurer, Secretary
Company Directors
Michael Sinclair Chairman, Executive Chairman
Roger Crystal
Ann MacDougall Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Kevin Pollack
Gabrielle Silver Independent Director, Nominating Committee Member
Thomas T. Thomas Independent Director, Audit Committee Member, Compensation Committee Member, Nominating Committee Member
Geoffrey Wolf Independent Director, Audit Committee Member, Nominating Committee Member
Service Providers
Accounting/Auditing Firm
MaloneBailey, LLP
9801 Westheimer Road
Suite 1100
Houston, TX, 77042
United States
 
Securities Counsel
DLA Piper
1251 Avenue of the Americas
New York, NY, 10020-1104
United States
 
Investor Relations Firm
Argot Partners
200 Park Avenue South
Suite 1515
New York, NY, 10003
United States
 
Company History
  • Formerly=Lightlake Therapeutics Inc. until 3-2016
  • Formerly=Madrona Ventures, Inc. until 10-2009
OPNT Security Details
Share Structure
Market Value1 $13,670,325 a/o May 26, 2017
Authorized Shares 200,000,000 a/o May 01, 2017
Outstanding Shares 2,049,524 a/o May 01, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
VStock Transfer LLC
Shareholders
Shareholders of Record 148 a/o Oct 28, 2016
Short Selling Data
Short Interest 861 (41.38%)
Apr 28, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security